Results 231 to 240 of about 3,038,700 (252)

Efficacy and Safety of the Felix NeuroAI Wristband for Essential Tremor: Results of a 1‐Year Open‐Label Extension Trial

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Essential tremor (ET) impacts daily activities and quality of life. A pivotal study of a transcutaneous peripheral nerve stimulation (TPNS) device, the Felix NeuroAI Wristband, led to Food and Drug Administration (FDA) clearance in 2025. Objective The aim of the study was to report 1‐year follow‐up results.
Stuart H. Isaacson, Yongsheng Hu, William G. Ondo, Wen Lv, Xiaodong Zhu, Yuan Yuan, Alberto J. Espay, David Kreitzman, Sheng‐Han Kuo, Salima Brillman, Holly A. Shill, Kelly E. Lyons, Zhi Yang, Qi Zhao, Zhen Zhang, Rajesh Pahwa   +15 more
wiley   +1 more source

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications

Muscle &Nerve, EarlyView.
ABSTRACT Peripheral nerve injuries (PNIs) are a common cause of long‐term motor and sensory disability despite advances in microsurgical repair. Functional recovery following PNI depends not only on axonal regeneration, but also on preservation of distal nerve pathways, maintenance of neuromuscular junction integrity, prevention of irreversible muscle ...
Sarah M. Smith, Kirsten M. Schlosser, Ranee Munaim, Stephanie H. Vu, JulieAnn H. Uh, Yusha K. Liu   +5 more
wiley   +1 more source

Daily Life Challenges and Unmet Medical Needs of Patients With Inclusion Body Myositis: Insights From a Comprehensive Questionnaire Survey

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Inclusion body myositis (IBM) is a progressive inflammatory myopathy characterized by weakness of the quadriceps and finger flexors, and often accompanied by dysphagia, resulting in substantial functional impairment. However, there is limited data on the daily living conditions and support needs of patients.
Satoshi Yamashita, Tomoyuki Otsu, Kazuma Sugie, Naoki Suzuki, Masashi Aoki, Hiroyuki Murai   +5 more
wiley   +1 more source

The Benefits of Adding Non‐Antimuscarinic Pharmaceuticals in Combination With Beta‐3 Agonists for Overactive Bladder Treatment: A Systematic Review

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Antimuscarinics, as the current first‐line pharmacologic therapies for overactive bladder, exhibit low patient adherence and high rates of reported side effects. As a modern alternative pharmaceutical treatment, beta‐3 agonists, which relax the urinary bladder, may be more tolerable for patients, increasing adherence and ...
Felicity Smith, Charlotte Phelps, Christian Moro   +2 more
wiley   +1 more source

Non-transdermal microneedles for advanced drug delivery [PDF]

Advanced Drug Delivery Reviews, 2020
Microneedles (MNs) have been used to deliver drugs for over two decades. These platforms have been proven to increase transdermal drug delivery efficiency dramatically by penetrating restrictive tissue barriers in a minimally invasive manner.
Marcus J Goudie, Han-Jun Kim, WonHyoung Ryu   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Transdermal drug delivery and patches—An overview

Medical Devices & Sensors, 2020
Nuggehalli M Ravindra
exaly  

Permeation enhancers in transdermal drug delivery: benefits and limitations

Expert Opinion on Drug Delivery, 2020
Kateřina Vávrová, Monika Kopečná, Andrej Kováčik   +2 more
exaly  

Overcoming skin barriers through advanced transdermal drug delivery approaches

Journal of Controlled Release, 2022
Mukta Agrawal, Amit Alexander, Vivek Phatale   +2 more
exaly  

Permeation enhancer strategies in transdermal drug delivery

Drug Delivery, 2016
Goutam Rath, Amit Kumar Goyal, Tarun Garg   +2 more
exaly  

Microneedles for transdermal drug delivery

Advanced Drug Delivery Reviews, 2004
Mark Prausnitz
exaly